Targeting AKT-Dependent Regulation of Antioxidant Defense Sensitizes AKT-E17K Expressing Cancer Cells to Ionizing Radiation
Aberrant activation of the phosphatidyl-inositol-3-kinase/protein kinase B (AKT) pathway has clinical relevance to radiation resistance, but the underlying mechanisms are incompletely understood. Protection against reactive oxygen species (ROS) plays an emerging role in the regulation of cell surviv...
Main Authors: | Isabell Goetting, Safa Larafa, Katharina Eul, Mikhail Kunin, Burkhard Jakob, Johann Matschke, Verena Jendrossek |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.920017/full |
Similar Items
-
Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for δ-Tocotrienol
by: Fabrizio Fontana, et al.
Published: (2022-05-01) -
CXCL13 Activates Akt to Promote Radioresistance of Lung Cancer
by: GENG Shanshan, et al.
Published: (2020-01-01) -
Selective eradication of cancer displaying hyperactive Akt by exploiting the metabolic consequences of Akt activation
by: Veronique Nogueira, et al.
Published: (2018-04-01) -
SMAD4 inhibits glycolysis in ovarian cancer through PI3K/AKT/HK2 signaling pathway by activating ARHGAP10
by: Kui Wu, et al.
Published: (2024-02-01) -
Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib
by: Liwei Lang, et al.
Published: (2020-02-01)